News Briefing channel feed – Endpoints News

News Briefing channel feed

Crinetics’ $500M offering; Boehringer inks deal with macrocycles biotech

9 months ago

Scholar Rock aims to raise $275M; Vincerx to reshuffle pipeline focus

9 months ago

Galapagos investor gets board seat; OnKure completes merger with Reneo

9 months ago

Editas sells future CRISPR license fees; Plus, news about Oncolytics Biotech

9 months ago

FDA lifts partial hold on Avidity’s myotonic dystrophy drug; Orum's IPO in South Korea

9 months ago

Biohaven aims to raise $250M; Activist investor's stake in Galapagos exceeds 10%

9 months ago

CSPC, Alphamab Oncology make an ADC deal; Visen’s IPO in Hong Kong

9 months ago

Repair, Genevant ink deal worth up to $107M; 858 Therapeutics raises $50M

9 months ago

Corrected: Sanofi inks deal with I-Mab spinout; Wave discloses $175M offering on heels of DMD data

9 months ago

Capricor to begin filing DMD drug with FDA next month; Surrozen’s $10M milestone

9 months ago

Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC

9 months ago

Ascendis aims to raise $300M; Basilea inks up to $268M deal with BARDA

9 months ago

Capricor expands DMD pact with Nippon Shinyaku; AbbVie’s new eye deal

9 months ago

Nuvalent's $350M offering; FDA lifts partial hold on Zentalis drug

9 months ago

Valneva raises about €61M; Immuneering details new Phase 2a data

10 months ago

GSK’s mRNA flu shot is heading to Phase 3; Summit’s $235M offering

10 months ago

Xencor’s $175M offering; Viridian to raise $150M

10 months ago

Ionis’ $500M offering; Terns aims to raise $125M

10 months ago

Immunovant shares mid-stage Graves’ disease data; FDA lifts Rezolute’s hold

10 months ago

Basilea records $25M milestone; Connect Biopharma reduces workforce in China

10 months ago

Novartis pays $15M upfront to license Voyager program; Boehringer advances geographic atrophy drug

10 months ago

Vaxcyte aims to raise $1B after sharing pneumococcal vaccine data; More layoffs at Genentech

10 months ago

Denali details accelerated approval plans; Jazz's $850M private offering

10 months ago

Jacobio's China rights deal; Reneuron off the London exchange

10 months ago

First page Previous page 5 6 789 10 11 Next page Last page